Inovio Pharmaceuticals Inc Financial Flexibility Index
Inovio Pharmaceuticals Inc financial flexibility index. Inovio Pharmaceuticals Inc (INO) has a Financial Flexibility Index of -0.28x as of September 2025. Free cash flow of $-21.51 Million (operating CF $-21.57 Million minus capex $67.95K) represents 0% of total liabilities ($77.11 Million). See Inovio Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Inovio Pharmaceuticals Inc (1998–2024)
Financial flexibility index of Inovio Pharmaceuticals Inc from 1998 to 2024. Historical Financial Flexibility Index trend for Inovio Pharmaceuticals Inc across 27 annual periods. Check Inovio Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Inovio Pharmaceuticals Inc Financial Flexibility Index by Year (1998–2024)
Inovio Pharmaceuticals Inc financial flexibility index by year from 1998 to 2024. Year-by-year free cash flow to debt coverage for Inovio Pharmaceuticals Inc. For the full cash flow conversion analysis, see Inovio Pharmaceuticals Inc (INO) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.32x | $-103.59 Million | $-104.08 Million | $44.69 Million | ▼ -0.2% |
| 2023 | -2.31x | $-124.04 Million | $-124.37 Million | $53.60 Million | ▼ -35.6% |
| 2022 | -1.71x | $-215.25 Million | $-216.22 Million | $126.17 Million | ▲ +23.4% |
| 2021 | -2.23x | $-214.48 Million | $-215.71 Million | $96.27 Million | ▲ +0.7% |
| 2020 | -2.24x | $-176.46 Million | $-177.98 Million | $78.63 Million | ▼ -221.0% |
| 2019 | -0.70x | $-96.86 Million | $-97.85 Million | $138.55 Million | ▲ +56.9% |
| 2018 | -1.62x | $-71.47 Million | $-73.55 Million | $44.08 Million | ▼ -37.1% |
| 2017 | -1.18x | $-52.92 Million | $-63.21 Million | $44.75 Million | ▼ -1.5% |
| 2016 | -1.16x | $-58.62 Million | $-62.56 Million | $50.33 Million | ▼ -357.2% |
| 2015 | -0.25x | $-9.66 Million | $-12.44 Million | $37.91 Million | ▲ +81.9% |
| 2014 | -1.40x | $-28.44 Million | $-29.82 Million | $20.25 Million | ▼ -226.9% |
| 2013 | -0.43x | $-15.20 Million | $-15.38 Million | $35.38 Million | ▲ +80.0% |
| 2012 | -2.15x | $-22.07 Million | $-22.31 Million | $10.28 Million | ▼ -45.1% |
| 2011 | -1.48x | $-19.59 Million | $-19.76 Million | $13.24 Million | ▼ -14.0% |
| 2010 | -1.30x | $-11.63 Million | $-11.94 Million | $8.97 Million | ▼ -81.3% |
| 2009 | -0.72x | $-13.92 Million | $-14.08 Million | $19.44 Million | ▼ -35.0% |
| 2008 | -0.53x | $-10.54 Million | $-11.13 Million | $19.88 Million | ▲ +57.4% |
| 2007 | -1.24x | $-10.87 Million | $-11.51 Million | $8.74 Million | ▼ -172.6% |
| 2006 | -0.46x | $-5.68 Million | $-7.04 Million | $12.45 Million | ▲ +79.2% |
| 2005 | -2.19x | $-12.05 Million | $-12.34 Million | $5.51 Million | ▼ -76.5% |
| 2004 | -1.24x | $-6.70 Million | $-6.80 Million | $5.40 Million | ▲ +45.5% |
| 2003 | -2.28x | $-2.69 Million | $-2.75 Million | $1.18 Million | ▲ +15.3% |
| 2002 | -2.69x | $-4.55 Million | $-4.96 Million | $1.69 Million | ▲ +44.6% |
| 2001 | -4.85x | $-8.11 Million | $-8.37 Million | $1.67 Million | ▲ +8.9% |
| 2000 | -5.33x | $-8.50 Million | $-8.79 Million | $1.60 Million | ▼ -100.3% |
| 1999 | -2.66x | $-5.80 Million | $-6.30 Million | $2.18 Million | ▲ +31.2% |
| 1998 | -3.87x | $-5.80 Million | $-6.30 Million | $1.50 Million | — |